3+ hour, 42+ min ago  (206+ words) Apr. 10, 2026 at 7: 28am Proteins are the essential molecular machines that carry out life's functions, but their complex structures have made decoding their sequences a major challenge. This new technique promises to revolutionize our understanding of biology by providing a powerful tool…...

2+ hour, 7+ min ago  (361+ words) A surprising discovery about how dragonflies detect red light has revealed an unlikely link to human vision and could potentially open doors for next-generation medical treatments. Scientists at Osaka Metropolitan University (OMU) in Japan have found that dragonflies and humans…...

9+ hour, 30+ min ago  (181+ words) Seoul Economic Daily Algenomics (476830) announced on the 10th that it has signed a strategic memorandum of understanding (MOU) with Surgynex, a company specializing in lipid nanoparticle (LNP) delivery systems, for the development of LNP-based precision-guided next-generation RNA gene therapies. The two…...

2+ hour, 54+ min ago  (708+ words) On the opening day of the 4th Cell & Gene Therapy Innovation & Access Congress Asia in Seoul, discussions moved quickly past familiar narratives of promise and into a more exacting question: how to design cell therapies that behave predictably in complex biological…...

1+ day, 1+ hour ago  (259+ words) Nature Genetics (2026)Cite this article With a focus on RNA-based interventions, we identify a suite of previously underappreciated and functionally diverse genes that control cancer cell susceptibility to targeted T cell-mediated elimination. We further introduce a scalable strategy to decode…...

2+ hour, 39+ min ago  (283+ words) KENNEDY SPACE CENTER, Fla. , April 9, 2026 /PRNewswire/ -- Eascra Biotech is leveraging the International Space Station (ISS) National Laboratory to advance the next generation of targeted cancer treatments through the development of Janus base nanomaterials (JBNs). JBNs are engineered from synthetic DNA-inspired…...

1+ hour, 59+ min ago  (206+ words) Preclinical data on lead program DBXO-1 to be presented at AACR 2026 Apr. 10, 2026 at 3: 39am A biotechnology company developing novel immunotherapies to unlock the potential of T cell engagers in solid tumors. The founder and CEO of Deck Bio, a Stanford-trained protein…...

7+ hour, 44+ min ago  (936+ words) Med Device Online Guest Column | April 10, 2026 Drug-Device Combination Products: 4 Evolving Platforms For 2026 By Andrey Meshcheryakov, Recombinators Biologic drug delivery is entering a new phase. For years, the industry's center of gravity was the molecule itself: potency, selectivity, durability, immunogenicity. In…...

6+ hour, 12+ min ago  (510+ words) Circular RNAs: From Anomalies to Cellular Regulators 2 Biogenesis and functional roles of circ RNAs 3 Circ RNAs, adipose tissue, and obesity 5 Current challenges and future directions Front. Genet. , 10 April 2026 Sec. Epigenomics and Epigenetics Gabriel O. Salcedo-Rivas 1 1. Tecnologico de Monterrey, School of Engineering…...

8+ hour, 36+ min ago  (11+ words) Car-T therapy rewires immunity to reverse three autoimmune diseases - CHOSUNBIZ'Chosunbiz...